Suppr超能文献

[DNA脉冲细胞光度法在肾癌中的应用可能性]

[Possibilities of DNA impulse cytophotometry in kidney cancers].

作者信息

Kiesewetter F, Hornstein O P, Hermanek P, Herrlinger A, Eberhard S

出版信息

Urologe A. 1987 May;26(3):162-7.

PMID:3603902
Abstract

DNA flow cytometry (DNA-FCM) is a modern technique allowing quantitative tumor cell analysis. In tissue samples from 62 renal carcinomas, ploidy was determined and cell cycle analysis performed by DNA-FCM. We checked for correlation between the FCM data and the tumor stage according to Robson the histological grade after Hermanek, and the condition according to the combined staging and grading system. With reference to the stage-grade system, the DNA aneuploidy rate increased significantly from tumors with increasing degree of malignancy. Tumors classed according to Robson's classification system as highly malignant exhibited higher DNA aneuploidy rates. The 15 tumors that had metastasized showed higher DNA indices and higher proportions of cells in S-phase than did the 47 tumors without metastases. When used in conjunction with the stage-grade classification for renal carcinomas, DNA-FCM analysis provides useful information about the proliferative behavior, including the susceptibility of these tumors to chemotherapy.

摘要

DNA流式细胞术(DNA-FCM)是一种可进行肿瘤细胞定量分析的现代技术。在取自62例肾癌的组织样本中,通过DNA-FCM确定了倍性并进行了细胞周期分析。我们根据罗布森分期法检查了FCM数据与肿瘤分期之间的相关性,根据赫尔曼内克法检查了组织学分级,并根据联合分期和分级系统检查了病情。参照分期-分级系统,随着恶性程度的增加,肿瘤的DNA非整倍体率显著升高。根据罗布森分类系统归类为高度恶性的肿瘤表现出更高的DNA非整倍体率。15例发生转移的肿瘤比47例未发生转移的肿瘤表现出更高的DNA指数和更高比例的S期细胞。当与肾癌的分期-分级分类结合使用时,DNA-FCM分析可提供有关增殖行为的有用信息,包括这些肿瘤对化疗的敏感性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验